The dopaminergic system in hypertension

Clinical Science

Volumn 112, Issue 11-12, 2007, Pages 583-597

  Zeng, Chunyu ^a   Zhang, Meng ^a   Asico, Laureano D ^b   Eisner, Gilbert M ^b   Jose, Pedro A ^b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Artery; Blood pressure; Central nervous system; Dopamine receptor; Hypertension; Kidney; Sodium homoeostasis

Indexed keywords

DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE 5 RECEPTOR; ECOPIPAM; PHOSPHOLIPASE D; REACTIVE OXYGEN METABOLITE;

ADRENERGIC SYSTEM; BLOOD PRESSURE REGULATION; CENTRAL NERVOUS SYSTEM; DIURETIC ACTIVITY; DNA POLYMORPHISM; DOPAMINE METABOLISM; DOPAMINERGIC SYSTEM; EPITHELIUM CELL; HUMAN; HYPERTENSION; MUSCLE CONTRACTILITY; NONHUMAN; PATHOGENESIS; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RESISTANCE BLOOD VESSEL; REVIEW; SODIUM EXCRETION; SODIUM TRANSPORT; VASCULAR SMOOTH MUSCLE;

BLOOD PRESSURE; DOPAMINE; GASTROINTESTINAL TRACT; HUMANS; HYPERTENSION; KIDNEY; MUSCLE, SMOOTH, VASCULAR; RECEPTORS, DOPAMINE; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; RECEPTORS, DOPAMINE D4; RECEPTORS, DOPAMINE D5;

EID: 34249779228     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20070018     Document Type: Review

References (186)

1. Gong, M. and Hubner, N. (2006) Molecular genetics of human hypertension. Clin. Sci. 110, 315-326
2. Hajjar, I. and Kotchen, T. A. (2003) Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA, J. Am. Med. Assoc. 290, 199-206
3. Touyz, R. M. (2005) Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: role of angiotensin II. Exp. Physiol. 90, 449-455
4. 3 dopamine receptor and essential hypertension. Curr. Hypertens. Rev. 2, 247-253
5. 1 dopamine receptor function. Cardiovasc. Hematol. Agents Med. Chem. 4, 369-377
6. Moore, J. H. and Williams, S. M. (2002) New strategies for identifying gene-gene interactions in hypertension. Ann. Med. 34, 88-99
7. Marteau, J. B., Zaiou, M., Siest, G. and Visvikis-Siest, S. (2005) Genetic determinants of blood pressure regulation. J. Hypertens. 23, 2127-2143
8. Coy, V. (2005) Genetics of essential hypertension. J. Am. Acad. Nurse Pract. 17, 219-224
9. Kunes, J. and Zicha, J. (2006) Developmental windows and environment as important factors in the expression of genetic information: a cardiovascular physiologist's view. Clin. Sci. 111, 295-305
10. Haddy, F. J. (2006) Role of dietary salt in hypertension. Life Sci. 79, 1585-1592
11. Burnier, M., Bochud, M. and Maillard, M. (2006) Proximal tubular function and salt sensitivity. Curr. Hypertens. Rep. 8, 8-15
12. Katori, M. and Majima, M. (2006) A missing link between a high salt intake and blood pressure increase. J. Pharmacol. Sci. 100, 370-390
13. Ortiz, P. A. and Garvin, J. L. (2001) Intrarenal transport and vasoactive substances in hypertension. Hypertension 38, 621-624
14. Hussain, T. and Lokhandwala, M. F. (2003) Renal dopamine receptors and hypertension. Exp. Biol. Med. 228, 134-142
15. Aviv, A., Hollenberg, N. K. and Weder, A. (2004) Urinary potassium excretion and sodium sensitivity in blacks. Hypertension 43, 707-713
16. Granger, J. P., Abram, S., Stec, D. et al. (2006) Endothelin, the kidney, and hypertension. Curr. Hypertens. Rep. 8, 298-303
17. Lifton, R. P., Wilson, F. H., Choate, K. A. and Geller, D. S. (2002) Salt and blood pressure: new insight from human genetic studies. Cold Spring Harbor Symp. Quant. Biol. 67, 445-450
18. Vieira-Coelho, M. A., Gomes, P., Serrao, M. P. and Soares-da-Silva, P. (1997) Renal and intestinal autocrine monoaminergic systems: dopamine versus 5-hydroxytryptamine. Clin. Exp. Hypertens. 19, 43-58
19. Soares-da-Silva, P., Fernandes, M. H. and Pinto-do-O, P. C (1994) Cell inward transport of L-DOPA and 3-O-methyl-L-DOPA in rat renal tubules. Br. J. Pharmacol. 112, 611-615
20. Pinho, M. J., Serrao, M. P., Gomes, P. et al. (2004) Over-expression of renal LAT1 and LAT2 and enhanced L-DOPA uptake in SHR immortalized renal proximal tubular cells. Kidney Int. 66, 216-226
21. Ibarra, F. R., Aguirre, J., Nowicki, S. et al. (1996) Demethylation of 3-O-methyldopa in the kidney: a possible source for dopamine in urine. Am. J. Physiol. 270, F862-F868
22. Kuchel, O. G. and Kuchel, G. A. (1991) Peripheral dopamine in pathophysiology of hypertension. Interaction with aging and lifestyle. Hypertension 18, 709-721
23. Damasceno, A., Santos, A., Serrao, P. et al. (1999) Deficiency of renal dopaminergic-dependent natriuretic response to acute sodium load in black salt-sensitive subjects in contrast to salt-resistant subjects. J. Hypertens 17, 1995-2001
24. Clark, B. A., Rosa, R. M., Epstein, F. H. et al. (1992) Altered dopaminergic responses in hypertension. Hypertension 19, 589-594
25. Romero-Vecchione, E., Vasquez, J., Lema, G. et al. (1995) Low urinary dopamine excretion associated to low sodium excretion in normotensive Piaroa Amazonian ethnia compared to urban subjects. Invest. Clin. 36, 61-71
26. Gill, Jr, J. R., Grossman, E. and Goldstein, D. S. (1991) High urinary dopa and low urinary dopamine-to-dopa ratio in salt-sensitive hypertension. Hypertension 18, 614-621
27. Saito, I., Takeshita, E., Saruta, T. et al. (1986) Urinary dopamine excretion in normotensive subjects with or without family history of hypertension. J. Hypertens. 4, 57-60
28. Saito, I., Itsuji, S., Takeshita, E. et al. (1994) Increased urinary dopamine excretion in young patients with essential hypertension. Clin. Exp. Hypertens. 16, 29-39
29. Grossman, E., Hoffman, A., Tamrat, M. et al. (1991) Endogenous dopa and dopamine responses to dietary salt loading in salt-sensitive rats. J. Hypertens. 9, 259-263
30. Stier, Jr, C. T., Itskovitz, H. D. and Chen, Y. H. (1993) Urinary dopamine and sodium excretion in spontaneously hypertensive rats. Clin. Exp. Hypertens. 15, 105-123
31. Yoshimura, M., Kambara, S., Okabayashi, H. et al. (1987) Effect of decreased dopamine synthesis on the development of hypertension induced by salt loading in spontaneously hypertensive rats. Clin. Exp. Hypertens. A 9, 1141-1157
32. Jose, P. A., Eisner, G. M., Drago, J. et al. (1996) Dopamine receptor signaling defects in spontaneous hypertension. Am. J. Hypertens. 9, 400-405
33. Siragy, H. M., Felder, R. A., Howell, N. L. et al. (1989) Evidence that intrarenal dopamine acts as a paracrine substance at the renal tubule. Am. J. Physiol. 257, F469-F477
34. O'Connell, D. P., Ragsdale, N. V., Boyd, D. G. et al. (1997) Differential human renal tubular responses to dopamine type 1 receptor stimulation are determined by blood pressure status. Hypertension 29, 115-122
35. 2-like receptors on renal function. Am. J. Physiol. 275, R986-R989
36. 3 receptor action in rat aortic or mesenteric vascular smooth muscles. Hypertension 43, 673-679
37. 2-like dopamine receptor interaction in the spontaneously hypertensive rat. Am. J. Physiol. Regulatory Integrative Comp. Physiol. 281, R1071-R1078
38. 1A receptor protein in rat kidneys. Am. J. Physiol. 268, F1185-F1197
39. 1 receptor in rat IEC-6 intestinal epithelial cells. Am. J. Physiol. Regulatory Integrative Comp. Physiol. 287, R772-R779
40. 1A receptors in the rat small intestine. J. Surg. Res. 54, 616-620
41. Mezey, E., Eisenhofer, G., Hansson, S. et al. (1998) Dopamine produced by the stomach may act as a paracrine/autocrine hormone in the rat. Neuroendocrinology 67, 336-348
42. Amenta, F., Ricci, A., Tayebati, S. K. and Zaccheo, D. (2002) The peripheral dopaminergic system: morphological analysis, functional and clinical applications. Ital. J. Anat. Embryol. 107, 145-146
43. 5 dopamine receptors in the nephron. Hypertension 41, 604-610
44. 1 receptor protein in the human heart and kidney. Hypertension 30, 725-729
45. 1A receptor gene in proximal tubule of rat kidneys. Am. J. Physiol. 264, F280-F285
46. Ricci, A., Amenta, F., Bronzetti, E. et al. (2002) Age-related changes of dopamine receptor protein immunoreactivity in the rat mesenteric vascular tree. Mech. Ageing Dev. 123, 537-546
47. Amenta, F., Barili, P., Bronzetti, E. et al. (2000) Localization of dopamine receptor subtypes in systemic arteries. Clin. Exp. Hypertens. 22, 277-288
48. 2 receptor mRNAs in the rat systemic and pulmonary vasculatures. Mol. Cell 9, 417-421
49. 1A receptor in the gastrointestinal tract. Am. J. Physiol. Regulatory Integrative Comp. Physiol. 279, R599-R609
50. Amenta, F., Ricci, A., Rossodivita, I. et al. (2001) The dopaminergic system in hypertension. Clin. Exp. Hypertens. 23, 15-24
51. Hansell, P. and Fasching, A. (1991) The effect of dopamine receptor blockade on natriuresis is dependent on the degree of hypervolemia. Kidney Int. 39, 253-258
52. Sanada, H., Xu, J., Watanabe, H. et al. (2000) Differential expression and regulation of dopamine-1 (D-1) and dopamine-5 (D-5) receptor function in human kidney. Am. J. Hypertens. 13, 156A
53. Eklof, A. C. (1997) The natriuretic response to a dopamine DA1 agonist requires endogenous activation of dopamine DA2 receptors. Acta Physiol. Scand. 160, 311-314
54. Bacic, D., Kaissling, B., McLeroy, P. et al. (2003) Dopamine acutely decreases apical membrane Na/H exchanger NHE3 protein in mouse renal proximal tubule. Kidney Int. 64, 2133-2141
55. 1 dopamine agonists. Am. J. Physiol. 264, F1032-F1037
56. +/phosphate cotransporter NaPi-IIa in mouse kidney and OK cells. Am. J. Physiol. Renal Physiol. 288, F740-F747
57. - exchanger in immortalized SHR proximal tubular epithelial cells. Am. J. Physiol. Renal Physiol. 286, F1120-F1126
58. Efendiev, R., Cinelli, A. R., Leibiger, I. B. et al. (2006) FRET analysis reveals a critical conformational change within the Na, K-ATPase α1 subunit N-terminus during GPCR-dependent endocytosis. FEBS Lett. 580, 5067-5070
59. +-ATPase in rat renal proximal tubules. Eur. J. Pharmacol. 411, 61-66
60. - cotransporter in rabbits and normotensive rats but not in spontaneously hypertensive rats. Kidney Int. 57, 534-543
61. 1A receptor induces antinatriuresis in conscious rats. Hypertension 33, 504-510
62. 1 antagonist, on smoked cocaine self-administration by humans. Psychopharmacology 155, 330-337
63. 1A dopamine receptor in the pathogenesis of genetic hypertension. J. Clin. Invest. 97, 2283-2288
64. 1 receptor gene polymorphism is associated with essential hypertension. Hypertension 36, 183-186
65. Chatziantoniou, C., Ruan, X. and Arendshorst, W. J. (1995) Defective G protein activation of the cAMP pathway in rat kidney during genetic hypertension. Proc. Natl. Acad. Sci. U.S.A. 92, 2924-2928
66. +-pump activity by dopamine in rat tail arteries. Eur. J. Pharmacol. 284, 289-297
67. Ventura, H. O., Messerli, F. H., Frohlich, E. D. et al. (1984) Immediate hemodynamic effects of a dopamine-receptor agonist (fenoldopam) in patients with essential hypertension. Circulation 69, 1142-1145
68. Edwards, R. M. (1985) Response of isolated renal arterioles to acetylcholine, dopamine, and bradykinin. Am. J. Physiol. 248, F183-F189
69. Yamauchi, M., Kobayashi, Y., Shimoura, K. et al. (1992) Endothelium-dependent and -independent relaxation by dopamine in the rabbit pulmonary artery. Clin. Exp. Pharmacol. Physiol. 19, 401-410
70. 3 dopamine receptor transregulation in hypertension. Hypertension 43, 654-660
71. +-ATPase during high-salt diet in young but not in adult rats. Am. J. Physiol. 75, G1317-G1323
72. +-ATPase activity in Caco-2 and rat jejunal epithelial cells: effects of dopamine. Life Sci. 69, 1969-1981
73. Safsten, B. (1993) Duodenal bicarbonate secretion and mucosal protection. Neurohumoral influence and transport mechanisms. Acta Physiol. Scand. Suppl. 613, 1-4
74. Donowitz, M., Elta, G. and Battisti, L. (1983) Effect of dopamine and bromocriptine on rat ileal and colonic transport. Stimulation of absorption and reversal of cholera toxin-induced secretion. Gastroenterology 84, 516-523
75. Felder, R. A., Seikaly, M. G., Cody, P. et al. (1990) Attenuated renal response to dopaminergic drugs in spontaneously hypertensive rats. Hypertension 15, 560-569
76. Chen, C. and Lokhandwala, M. F. (1992) An impairment of renal tubular DA-1 receptor function as the causative factor for diminished natriuresis to volume expansion in spontaneously hypertensive rats. Clin. Exp. Hypertens. 14, 615-628
77. +-ATPase activity is lacking in Dahl salt-sensitive rats. Hypertension 21, 767-771
78. Chen, C., Beach, R. E. and Lokhandwala, MF. (1993) Dopamine fails to inhibit renal tubular sodium pump in hypertensive rats. Hypertension 21, 364-372
79. + exchanger interactions in the kidney in hypertension. Hypertension 36, 395-399
80. Sanada, H., Jose, P. A., Hazen-Martin, D. et al. (1999) Dopamine-1 receptor coupling defect in renal proximal tubule cells in hypertension. Hypertension 33, 1036-1042
81. Felder, R. A., Sanada, H., Xu, J. et al. (2002) G protein-coupled receptor kinase 4 gene variants in human essential hypertension. Proc. Natl. Acad. Sci. U.S.A. 99, 3872-3877
82. Bengra, C., Mifflin, T. E., Khripin, Y. et al. (2002) Genotyping of essential hypertension single-nucleotide polymorphisms by a homogeneous PCR method with universal energy transfer primers. Clin. Chem. 48, 2131-2140
83. Sanada, H., Yatabe, J., Midorikawa, S. et al. (2006) Single-nucleotide polymorphisms for diagnosis of salt-sensitive hypertension. Clin. Chem. 52, 352-360
84. Speirs, H. J., Katyk, K., Kumar, N. N. et al. (2004) Association of G-protein-coupled receptor kinase 4 haplotypes, but not HSD3B1 or PTP1B polymorphisms, with essential hypertension. J. Hypertens. 22, 931-936
85. Gu, D., Su, S., Ge, D. et al. (2006) Association study with 33 single-nucleotide polymorphisms in 11 candidate genes for hypertension in Ghinese. Hypertension 47, 1147-1154
86. Williams, S. M., Addy, J. H., Phillips, III, J. A. et al. (2000) Combinations of variations in multiple genes are associated with hypertension. Hypertension 36, 2-6
87. Williams, S. M., Ritchie, M. D., Phillips, III, J. A. et al. (2004) Multilocus analysis of hypertension: a hierarchical approach. Hum. Hered. 57, 28-38
88. Province, M. A., Arnett, D. K., Hunt, S. C. et al. (2000) Association between the α-adducin gene and hypertension in the HyperGEN Study. Am. J. Hypertens. 13, 710-718
89. Allayee, H., de Bruin, T. W., Michelle Dominguez, K. et al. (2001) Genome scan for blood pressure in Dutch dyslipidemic families reveals linkage to a locus on chromosome 4p. Hypertension 38, 773-778
90. Casari, G., Barlassina, C., Cusi, D. et al. (1995) Association of the α-adducin locus with essential hypertension. Hypertension 25, 320-326
91. Cai, G., Cole, S. A., Freeland-Graves, J. H. et al. (2004) Principal component for metabolic syndrome risk maps to chromosome 4p in Mexican Americans: the San Antonio Family Heart Study. Hum. Biol. 76, 651-665
92. Zhu, H., Lu, Y., Wang, X. et al. (2006) The G protein-coupled receptor kinase 4 gene affects blood pressure in young normotensive twins. Am. J. Hypertens. 19, 61-66
93. Zhu, H., Lu, Y., Wang, X. et al. (2006) The G protein-coupled receptor kinase 4 gene modulates stress-induced sodium excretion in black normotensive adolescents. Pediatr. Res. 60, 440-442
94. Sanada, H., Yatabe, J., Midorikawa, S. et al. (2006) Amelioration of genetic hypertension by suppression of renal G protein-coupled receptor kinase type 4 expression. Hypertension 47, 1131-1139
95. Murphy, M. B., Murray, C. and Shorten, G. D. (2001) Fenoldopam: a selective peripheral dopamine-receptor agonist for the treatment of severe hypertension. N. Engl. J. Med. 345, 1548-1557
96. Bughi, S., Horton, R., Antonipillai, I. et al. (1989) Comparison of dopamine ana fenoldopam effects on renal blood flow and prostacyclin excretion in normal and essential hypertensive subjects. J. Clin. Endocrinol. Metab. 69, 1116-1121
97. 1-like receptor agonist but not to an ACE inhibitor in conscious spontaneously hypertensive rats. J. Cardiovasc. Pharmacol. 34, 191-198
98. Lucas-Teixeira, V. A., Hussain, T., Serrao, P. et al. (2002) Intestinal dopaminergic activity in obese and lean Zucker rats: response to high salt intake. Clin. Exp. Hypertens. 24, 383-396
99. + atpase to inhibition by dopamine in spontaneous hypertensive and Wistar-Kyoto rats. Clin. Exp. Hypertens. 22, 455-469
100. Amenta, F. (1997) Light microscope autoradiography of peripheral dopamine receptor subtypes. Clin. Exp. Hypertens. 19, 27-41
101. 5 receptor expression is unchanged in peripheral blood lymphocytes in essential hypertension. Clin. Exp. Hypertens. 17, 1157-1172
102. 1. Nature 350, 614-619
103. 1B receptor subtype. J. Biol. Chem. 269, 27925-27931
104. 5 dopamine receptor regulation of reactive oxygen species production, NADPH oxidase, and blood pressure. Am. J. Physiol. Regulatory Integrative Comp. Physiol. 290, R96-R104
105. 5 dopamine receptor knockout mice and hypertension. J. Recept. Signal Transduction Res. 24, 149-164
106. 5 dopamine receptors in renal proximal tubule cells. Hypertension 45, 804-810
107. 1 receptor interaction in spontaneously hypertensive rats. Hypertension 42, 787-792
108. Chen, C. and Lokhandwala, M. F. (1995) Potentiation by enalaprilat of fenoldopam-evoked natriuresis is due to blockade of intrarenal production of angiotensin-II in rats. Naunvn Schmiedebergs Arch. Pharmacol. 352, 194-200
109. Clark, K. L., Hilditch, A., Robertson, M. J. and Drew, G. M. (1991) Effects of dopamine DA1-receptor blockade and angiotensin converting enzyme inhibition on the renal actions of fenoldopam in the anaesthetized dog. J. Hypertens. 9, 1143-1150
110. 1 dopamine receptor. Hypertension 42, 438A
111. Tamaki, T., Hura, C. E. and Kunau, Jr, R. T. (1989) Dopamine stimulates cAMP production in canine afferent arterioles via DA1 receptors. Am. J. Physiol. 256, H626-H629
112. Zhu, L., Zhao, R. R. and Zhang, W. F. (2000) Effects of dopamine receptor agonists on the cAMP content in arteries of the rabbit. Sheng Li Xue Bao 52, 247-245
113. Hall, A. S., Bryson, S. E., Vaughan, P. F. et al. (1993) Pharmacological characterization of the dopamine receptor coupled to cyclic AMP formation expressed by rat mesenteric artery vascular smooth muscle cells in culture. Br. J. Pharmacol. 110, 681-686
114. 1-like receptors. Arterioscler. Thromb. Vasc. Biol. 17, 3164-3173
115. 5 dopamine receptor regulation of phospholipase D. Am. J. Physiol. Heart Circ. Physiol. 288, H55-H61
116. 5 dopamine receptors have increased sympathetic tone and are hypertensive. J. Neurosci. 22, 10801-10810
117. Fink, G. D. (2005) Hypothesis: the systemic circulation as a regulated free-market economy, A new approach for understanding the long-term control of blood pressure. Clin. Exp. Pharmacol. Physiol. 32, 377-383
118. 2-adrenergic receptors and blood pressure using Dahl salt-sensitive rats. J. Hypertens. 12, 357-365
119. 5 dopamine receptor genes. Genomics 13, 968-973
120. Cohn, D. H., Shohat, T., Yahav, M. et al. (2000) A locus for an autosomal dominant form of progressive renal failure and hypertension at chromosome 1q21. Am. J. Hum. Genet. 67, 647-651
121. Cooper, R. S., Luke, A., Zhu, X. et al. (2002) Genome scan among Nigerians linking blood pressure to chromosomes 2, 3, and 19. Hypertension 40, 629-633
122. 5 dopamine receptor missense and nonsense variants: differences in dopamine binding affinities. Pharmacogenetics 9, 199-206
123. 3 receptors in the rat kidney: role in physiology and pathophysiology. Acta Physiol. Scand. 168, 219-223
124. 3 receptor gene produces renin-dependent hypertension. J. Clin. Invest. 102, 493-498
125. 3) as a target for neuroleptics. Nature 347, 146-151
126. 3 dopamine receptor gene. Hum. Genet. 87, 618-620
127. 2 subfamily of dopamine receptor genes in the kidnev. Am. J. Physiol. 266, F646-F650
128. 3 receptor protein in the rat kidney. Hypertension 32, 886-895
129. 3 receptor in proximal tubules of the rat kidney. J. Histochem. Cytochem. 52, 1647-1655
130. Barili, P., Sabbatini, M., Soares-da-Silva, P. and Amenta, F. (2002) The peripheral dopaminergic system: morphological analysis, functional and clinical applications. Ital. J. Anat. Embryol. 107, 145-167
131. Aperia, A. C. (2000) Intrarenal dopamine: a key signal in the interactive regulation of sodium metabolism. Annu. Rev. Physiol. 62, 621-647
132. Carey, R. M. (2001) Renal dopamine system: paracrine regulator of sodium homeostasis and blood pressure. Hypertension 38, 297-302
133. Sti'er, Jr, C. T., Cowden, E. A. and Allison, M. E. (1982) Effects of bromocriptine on single nephron and whole-kidnev function in rats. J. Pharmacol. Exp. Ther. 220, 366-370
134. +-ATPase in renal proximal tubules via the cAMP pathway. Eur. J. Pharmacol. 321, 259-263
135. 3 receptor functions? Biochem. Pharmacol. 52, 511-518
136. 3 receptor activation modulates renal function in anesthetized rats. Naunyn Schmiedebergs Arch. Pharmacol. 358, 690-693
137. 3 dopamine receptor: neurobiology and potential clinical relevance. Pharmacol. Rev. 49, 231-252
138. 3 dopamine receptors in SHRs. Am. J. Hypertens. 17, 96A
139. 3 receptor-mediated inhibition of renal NHE3 activity in SHR proximal tubular cells is a PLC-PKC-mediated event. Am. J. Physiol. Renal Physiol. 287, F1059-F1066
140. 3 receptor. Mol. Pharmacol. 52, 508-514
141. Wiederkehr, M. R., Di Sole, F., Collazo, R. et al. (2001) Characterization of acute inhibition of Na/H exchanger NHE-3 by dopamine in opossum kidney cells. Kidney Int. 59, 197-209
142. 2 receptors. Am. J. Physiol. 259, F924-F928
143. 2 dopamine receptor synergism. Nature 347, 386-388
144. Satoh, T., Cohen, H. T. and Katz, A. I. (1993) Intracellular signaling in the regulation of renal Na-K-ATPase. II. Role of eicosanoids. J. Clin. Invest. 91, 409-415
145. 1 dopamine receptor in immortalized renal proximal tubule cells. Hypertension 47, 573-579
146. Siragy, H. M., Felder, R. A., Peach, M. J. and Carey, R. M. (1992) Intrarenal DA2 dopamine receptor stimulation in the conscious dog. Am. J. Physiol. 262, F932-F938
147. 3 receptors and salt-dependent hypertension. J. Am. Soc. Nephrol. 12, 2272-2279
148. 3 dopamine receptor-mediated regulation of spontaneous secretory activity. J. Gen. Physiol. 115, 697-706
149. 3 receptor causes a shift from cAMP related to PGE2 related signal transduction mechanisms in transfected CHO cells. J. Med. Genet. 41, 867-871
150. 3 receptor gene in schizophrenia patients: identification of the Ala38Thr polymorphism and suggested association between DRD3 haplotypes and schizophrenia. Mol. Psychiatry 5, 433-438
151. 3 receptor gene is not associated with essential hypertension in the Japanese. Med. Sci. Monit. 8, CR1-CR4
152. James, K., Weitzel, L. R., Engelman, C. D. et al. (2003) Genome scan linkage results for longitudinal systolic blood pressure phenotypes in subjects from the Framingham Heart Study. BMC Genet. 4, (Suppl. 1), S83
153. Rice, T., Rankinen, T., Province, M. A. et al. (2000) Genome-wide linkage analysis of systolic and diastolic blood pressure: the Quebec Family Study. Circulation 102, 1956-1963
154. Shin, Y., Kumar, U., Patel, Y. et al. (2003) Differential expression of D2-like dopamine receptors in the kidney of the spontaneously hypertensive rat. J. Hypertens. 21, 199-207
155. 4 dopamine receptor-deficient mice. Hypertension 47, 288-295
156. Hussain, T., Abdul-Wahab, R., Kotak, D. K. and Lokhandwala, M. F. (1998) Bromocriptine regulates angiotensin II response on sodium pump in proximal tubules. Hypertension 32, 1054-1059
157. 3 dopamine receptor deficient mice. Zhonghua Xin Xue Guan Bing Za Zhi 33, 1132-1136
158. 1 angiotensin receptor expression in rat renal proximal tubule cells. Circ. Res. 99, 494-500
159. 3 receptors. Neuroscience 91, 911-924
160. 2 receptors in rat heart and coronary vessels. Clin. Exp. Pharmacol. Physiol. 29, 412-418
161. 2 receptor activation causes mitogencsis via p44/42 mitogcn-activated protein kinase in opossum kidney cells. J. Am. Soc. Nephrol. 12, 1844-1852
162. Li, X. X., Bek, M., Asico, L. D. et al. (2001) Adrenergic and endothelin B receptor-dependent hypertension in dopamine receptor tvpe-2 knockout mice. Hypertension 38, 303-308
163. Ueda, A., Ozono, R., Oshima, T. et al. (2003) Disruption of the type 2 dopamine receptor gene causes a sodium-dependent increase in blood pressure in mice. Am. J. Hvpertens. 16, 853-858
164. 2 receptor modulates sodium handling via local production of dopamine in the kidney. J. Cardiovasc. Pharmacol. 42, (Suppl. 1), S75-S79
165. + ATPase activity in murine LTK2 cells. Mol. Pharmacol. 49, 373-378
166. + ATPase activity through protein kinase A. Mol. Pharmacol. 43, 281-285
167. 2 dopamine receptor synergism. Pediatr. Res. 35, 377A
168. 2 receptor synergism. Nature 353, 164-167
169. 2 dopamine receptors mediate the potentiation of arachidonic acid release in Chinese hamster ovary cells. Mol. Pharmacol. 39, 364-369
170. +-ATPase in kidney of spontaneously hypertensive rats. Clin. Exp. Hypertens. 18, 963-974
171. Takemoto, F., Satoh, T., Cohen, H. T. and Katz, A. I. (1996) Regulation of Na-KATPase activity in the proximal tubule: role of the protein kinase C pathway and of eicosanoids. J. Membr. Biol. 152, 235-243
172. 2 receptor gene TaqI polymorphism. Hypertension 36, 177-182
173. 2 receptor and blood pressure in hyperglycaemic and normoglycaemic Chinese subjects. Clin. Endocrinol. 55, 605-611
174. Kren, V., Pravenec, M., Lu, S. et al. (1997) Genetic isolation of a region of chromosome 8 that exerts major effects on blood pressure and cardiac mass in the spontaneously hypertensive rat. J. Clin. Invest. 99, 577-581
175. 4 receptor with high affinity for the antipsychotic clozapine. Nature 350, 610-614
176. 4 dopamine receptor-mediated signaling events determined in transfected Chinese hamster ovary cells. J. Biol. Chem. 269, 11813-11819
177. 4 receptor expression in rat kidney: evidence for pre- and postjunctional localization. J. Histochem. Cytochem. 50, 1091-1096
178. 4 receptor. Brain Res. Mol. Brain Res. 29, 157-162
179. 4 receptor isoform mRNA and protein are expressed in the rat cortical collecting duct. Am. J. Physiol. 275, F742-F751
180. Schafer, J. A., Li, L. and Sun, D. (2000) The collecting duct, dopamine and vasopressin dependent hypertension. Acta Physiol. Scand. 168, 239-244
181. Saito, O., Ando, Y., Kusano, E. and Asano, Y. (2001) Functional characterization of basolateral and luminal dopamine receptors in rabbit CCD. Am. J. Physiol. Renal Physiol. 281, F114-F122
182. Stein, C. M., Song, Y., Elston, R. C. et al. (2003) Structural equation model-based genome scan for the metabolic syndrome. BMC Genet. 4, (Suppl. 1), S99
183. Ishimitsu, T., Hosoya, K., Tsukada, K. et al. (2001) Microsatellite DNA polymorphism of human adrenomedullin gene in normotensive subjects and patients with essential hypertension. Hypertension 38, 9-12
184. 4 receptor variants in the human population. Nature 358, 149-152
185. Sen, S., Nesse, R., Sheng, L. et al. (2005) Association between a dopamine-4 receptor polymorphism and blood pressure. Am. J. Hypertens. 18, 1206-1210
186. Rice, T., Rankinen, T., Chagnon, Y. C. et al. (2002) Genomewide linkage scan of resting blood pressure: HERITAGE Family Study. Health, risk factors, exercise training, and genetics. Hypertension 39, 1037-1043